Literature DB >> 23803066

miR-153 silencing induces apoptosis in the MDA-MB-231 breast cancer cell line.

Maricruz Anaya-Ruiz1, Jorge Cebada, Guadalupe Delgado-López, María Luisa Sánchez-Vázquez, José Luis Martín Pérez-Santos.   

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs (18-25 nucleotides) that post-transcriptionally modulate gene expression by negatively regulating the stability or translational efficiency of their target mRNAs. In this context, the present study aimed to evaluate the in vitro effects of miR-153 inhibition in the breast carcinoma cell line MDA-MB-231. Forty-eight hours after MDA-MB-231 cells were transfected with the miR-153 inhibitor, an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was utilized to determine the effects of miR-153 on cell viability. Flow cytometry analysis and assessment of caspase 3/7 activity were adopted to determine whether miR-153 affects the proliferation rates and apoptosis levels of MDA-MB-231 cells. Our results showed that silencing of miR-153 significantly inhibited growth when compared to controls at 48 hours, reducing proliferation by 37.6%, and inducing apoptosis. Further studies are necessary to corroborate our findings and examine the potential use of this microRNA in future diagnostic and therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23803066

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  16 in total

1.  Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression.

Authors:  Gulcin Tezcan; Berrin Tunca; Ahmet Bekar; Ferah Budak; Saliha Sahin; Gulsah Cecener; Unal Egeli; Mevlut Ozgur Taskapılıoglu; Hasan Kocaeli; Sahsine Tolunay; Hulusi Malyer; Cevdet Demir; Gulendam Tumen
Journal:  Am J Cancer Res       Date:  2014-09-06       Impact factor: 6.166

Review 2.  The role of microRNAs in human breast cancer progression.

Authors:  WenCheng Zhang; Jinbo Liu; Guangshun Wang
Journal:  Tumour Biol       Date:  2014-06-18

3.  The Ia-2β intronic miRNA, miR-153, is a negative regulator of insulin and dopamine secretion through its effect on the Cacna1c gene in mice.

Authors:  Huanyu Xu; Liron Abuhatzira; Gilberto N Carmona; Suryakiran Vadrevu; Leslie S Satin; Abner L Notkins
Journal:  Diabetologia       Date:  2015-07-04       Impact factor: 10.122

4.  MiR-153 promotes breast cancer cell apoptosis by targeting HECTD3.

Authors:  Xiaowei Wu; Lin Li; Yi Li; Zhihua Liu
Journal:  Am J Cancer Res       Date:  2016-07-01       Impact factor: 6.166

5.  Simultaneous learning of individual microRNA-gene interactions and regulatory comodules.

Authors:  Michael Roth; Pranjal Jain; Jinkyu Koo; Somali Chaterji
Journal:  BMC Bioinformatics       Date:  2021-05-10       Impact factor: 3.169

6.  MicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasion.

Authors:  Zhengliang Zhang; Jiangli Sun; Zhenghai Bai; Haijun Li; Shicai He; Rui Chen; Xiangming Che
Journal:  Onco Targets Ther       Date:  2015-02-02       Impact factor: 4.147

7.  MicroRNA-153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma.

Authors:  Zhenghai Bai; Jiangli Sun; Xiaobo Wang; Hai Wang; Honghong Pei; Zhengliang Zhang
Journal:  Oncol Rep       Date:  2015-06-11       Impact factor: 3.906

8.  MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-β2.

Authors:  Guangfeng Niu; Bin Li; Li Sun; Chenggong An
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

9.  Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.

Authors:  Insaf Fkih M'hamed; Maud Privat; Flora Ponelle; Frédérique Penault-Llorca; Abderraouf Kenani; Yves-Jean Bignon
Journal:  Cell Oncol (Dordr)       Date:  2015-09-21       Impact factor: 6.730

Review 10.  Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs.

Authors:  Abhineet Uppal; Mark K Ferguson; Mitchell C Posner; Samuel Hellman; Nikolai N Khodarev; Ralph R Weichselbaum
Journal:  Clin Exp Metastasis       Date:  2014-06-27       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.